A combination of barriers, including, of course, the high cost of drug development and the small profit margins have helped to drive companies out of the anti-infectious space.

Mr. Speaker, I move to suspend the rules and pass the bill (H.R. 3670) to amend the Communications Act of 1934 to expand and clarify the prohibition on provision of inaccurate caller identification information, and for other purposes, as…

Mr. Speaker, I yield such time as he may consume to the gentleman from New Jersey (Mr. Lance).

Mr. Speaker, I am the only other speaker left on my side, and I reserve the right to close. So I would yield to the gentleman from Utah or the gentlelady from New York if they wish to speak.

Mr. Speaker, the Congress is not spoofing when we say we are going to do something about those individuals that do try to spoof the American public. As has been pointed out, we passed a law back in, actually, it was the 2009 act, but we…

There is not even the facade of an attempt to say, this is what we think the health standards should be, which is the entire purpose of the Clean Air Act. And in this case, it is, again, nada, zip, nothing.

Thank you. This is just out of curiosity.

Well, bless their hearts.

If this regulation is implemented, Texas will bear a disproportionate share of the cost, 25 percent of the entire country's reductions has to be in Texas.

Mr. Speaker, I thank the distinguished chairman of the Rules Committee, Mr. Sessions. I hope we will yield back some of that time. First, I want to thank you, Mr. Chairman, for the leadership you have exhibited, not just in the Rules…

I don't buy the argument that you can close all these power plants and you are going to miraculously replace them.